Brass Corporation (TYO:2424)

Orchard Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is August - July.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Apr 30, 2025	Jul 31, 2024	Jul 31, 2023
Cash & Equivalents	2,335	1,635	2,347
Cash & Short-Term Investments	2,335	1,635	2,347
Cash Growth	42.90%	-30.34%	-
Receivables	65	26	52
Inventory	199	184	156
Other Current Assets	238	277	224
Total Current Assets	2,837	2,122	2,779
Property, Plant & Equipment	6,750	7,023	6,669
Long-Term Investments	811	661	645
Other Intangible Assets	54	72	96
Long-Term Deferred Tax Assets	1,027	936	950
Other Long-Term Assets	2	-	1
Total Assets	11,481	10,814	11,140
Accounts Payable	363	248	287
Accrued Expenses	180	119	111
Short-Term Debt	-	200	-
Current Portion of Long-Term Debt	1,089	1,259	2,140
Current Income Taxes Payable	909	508	973
Other Current Liabilities	1,143	899	944
Total Current Liabilities	3,684	3,233	4,455
Long-Term Debt	2,668	2,792	2,067
Other Long-Term Liabilities	776	828	838
Total Liabilities	7,328	7,026	7,513
Common Stock	100	100	100
Additional Paid-In Capital	1,009	1,009	1,009
Retained Earnings	3,351	2,985	2,746
Treasury Stock	-309	-309	-229
Comprehensive Income & Other	2	3	1
Shareholders' Equity	4,153	3,788	3,627
Total Liabilities & Equity	11,481	10,814	11,140
Total Debt	3,757	4,251	4,207
Net Cash (Debt)	-1,422	-2,616	-1,860
Net Cash Per Share	-267.28	-485.78	-342.25
Filing Date Shares Outstanding	5.32	5.32	5.43
Total Common Shares Outstanding	5.32	5.32	5.43
Working Capital	-847	-1,111	-1,676
Book Value Per Share	780.84	712.21	667.38
Tangible Book Value	4,099	3,716	3,531
Tangible Book Value Per Share	770.68	698.67	649.72
Order Backlog	-	2,321	2,307

Source: S&P Global Market Intelligence. Standard template. Financial Sources.